Crystalvue Medical Co Ltd(TW:6527)
NT$72.90-1.30 (-1.75%)
TW:6527
Crystalvue Medical Co Ltd financials statements
NT$72.90
At close:-1.30 (-1.75%)
Crystalvue Medical Co Ltd (6527) Income Statement
Crystalvue Medical Co Ltd Income Statement
Last quarter (Q2 2026), Crystalvue Medical Co Ltd's total revenue was NT$217.78M, a decrease of 15.07% from the same quarter last year. In Q2, Crystalvue Medical Co Ltd's net income was NT$42.34M. See Crystalvue Medical Co Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 949.05M | NT$ 868.03M | NT$ 823.96M | NT$ 795.46M | NT$ 721.61M | |
| NT$ 331.88M | NT$ 299.14M | NT$ 266.75M | NT$ 261.74M | NT$ 211.39M | |
| NT$ 150.93M | NT$ 154.14M | NT$ 142.59M | NT$ 136.94M | NT$ 122.93M | |
| Depreciation and Amortization | NT$ 17.82M | NT$ 29.35M | NT$ 29.17M | NT$ 26.15M | NT$ 40.88M |
| NT$ 198.76M | NT$ 189.36M | NT$ 149.73M | NT$ 169.59M | NT$ 151.22M | |
| NT$ 180.94M | NT$ 145.01M | NT$ 117.68M | NT$ 143.44M | NT$ 110.34M | |
| NT$ -1.93M | NT$ 14.37M | NT$ 2.06M | NT$ -998.00K | NT$ 20.70M | |
| NT$ 179.01M | NT$ 159.38M | NT$ 119.74M | NT$ 142.44M | NT$ 109.17M | |
| NT$ 146.98M | NT$ 127.15M | NT$ 103.40M | NT$ 115.03M | NT$ 77.24M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 5.80 | NT$ 5.01 | NT$ 4.13 | NT$ 4.59 | NT$ 3.09 |
| Diluted EPS | NT$ 5.80 | NT$ 4.95 | NT$ 4.09 | NT$ 4.51 | NT$ 3.05 |
| Weighted Average Shares Outstanding | 25.34M | 25.31M | 25.04M | 25.05M | 25.06M |
| Weighted Average Shares Outstanding (Diluted) | 25.34M | 25.69M | 25.28M | 25.51M | 25.37M |
Currency in TWD
